Background: Allogeneic hematopoietic stem cell transplantation in utero has been successfully used for the prenatal treatment of severe combined immunodeficiency syndrome. However, this therapy has not been successful in the treatment of other conditions in which the fetus is immunologically competent. Material and Methods: We reviewed the currently explored strategies to overcome these problems, including prenatal gene therapy using ex vivo transduced autologous hematopoietic cells or direct gene targeting in utero. Results: Some of the strategies such as stromal cell co-transplantation have been shown to be successful in preclinical studies. Similarly, prenatal gene transfer has been shown to be feasible in the fetal sheep model; however, safety concerns regarding transduction of fetal germ cells or maternal cells remain. Conclusion: Progress is being made in the exploration of new modalities of in utero transplantation although the procedure remains experimental and long-term clinical efficacy needs to be proven. In utero gene therapy seems feasible, but more animal studies are needed in order to assess its safety.

This content is only available via PDF.
© 2001 S. Karger GmbH, Freiburg
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.